シンバイオ製薬(4582)の空売り残高情報
- 空売り機関
- モルガン・スタンレーMUFG証券
- JPモルガン証券
- Barclays Capital Securities Ltd
- GOLDMAN SACHS INTERNATIONAL
- Citigroup Global Markets Limited
- MERRILL LYNCH INTERNATIONAL
- Nomura International plc
- UBS AG
- Macquarie Bank Limited
- BNP Paribas Financial Markets SNC formerly known as BNP Paribas Arbitrage SNC
- JANE STREET GLOBAL TRADING, LLC
- XTX Markets Pte Ltd
- Evo Fund(Evolution Japan Securities Co., Ltd.)
- 空売り機関 残り10件
空売りポジション
| 日付 | 報告 | 空売残高 | 増減率 | 株式数 |
|---|---|---|---|---|
| 2026 | ||||
| 07/29 | Barclays Capital Securities Ltd | 1.7% | +0.06% | 1,300,925株 +42,300株 |
| 07/27 | GOLDMAN SACHS INTERNATIONAL | 0.13% | -1.05% 義務消失 | 102,200株 -802,004株 |
| 07/27 | JPモルガン証券 | 1.3% | +0.02% | 996,651株 +11,500株 |
| 07/24 | Barclays Capital Securities Ltd | 1.64% | +0.13% | 1,258,625株 +97,400株 |
| 07/23 | Barclays Capital Securities Ltd | 1.51% | +0.1% | 1,161,225株 +82,200株 |
| 07/23 | モルガン・スタンレーMUFG証券 | 1.58% | -0.03% | 1,211,927株 -24,900株 |
| 07/23 | JPモルガン証券 | 1.28% | -0.02% | 985,151株 -9,800株 |
| 07/22 | モルガン・スタンレーMUFG証券 | 1.61% | +0.02% | 1,236,827株 +16,200株 |
| 07/22 | JPモルガン証券 | 1.3% | +0.73% | 994,951株 +558,100株 |
| 07/21 | GOLDMAN SACHS INTERNATIONAL | 1.18% | -0.03% | 904,204株 -26,700株 |
| 07/21 | モルガン・スタンレーMUFG証券 | 1.59% | -0.07% | 1,220,627株 -52,800株 |
| 07/21 | JPモルガン証券 | 0.57% | -0.73% | 436,851株 -557,800株 |
| 07/17 | GOLDMAN SACHS INTERNATIONAL | 1.21% | +0.11% | 930,904株 +84,200株 |
| 07/17 | JPモルガン証券 | 1.3% | +0.09% | 994,651株 +67,100株 |
| 07/16 | Barclays Capital Securities Ltd | 1.41% | +0.14% | 1,079,025株 +102,700株 |
| 07/16 | モルガン・スタンレーMUFG証券 | 1.66% | -0.07% | 1,273,427株 -54,900株 |
| 07/15 | モルガン・スタンレーMUFG証券 | 1.73% | -0.18% | 1,328,327株 -131,700株 |
| 07/13 | モルガン・スタンレーMUFG証券 | 1.91% | +0.02% | 1,460,027株 +11,800株 |
| 07/10 | Barclays Capital Securities Ltd | 1.27% | -0.09% | 976,325株 -70,100株 |
| 07/10 | Nomura International plc | 0.33% | -0.2% 義務消失 | 255,535株 -153,273株 |
| 07/09 | モルガン・スタンレーMUFG証券 | 1.89% | +0.11% | 1,448,227株 +84,500株 |
| 07/08 | Barclays Capital Securities Ltd | 1.36% | -0.17% | 1,046,425株 -125,000株 |
| 07/08 | モルガン・スタンレーMUFG証券 | 1.78% | +0.76% | 1,363,727株 +581,800株 |
| 07/08 | JPモルガン証券 | 1.21% | +0.11% | 927,551株 +84,700株 |
| 07/07 | Barclays Capital Securities Ltd | 1.53% | +0.08% | 1,171,425株 +59,000株 |
| 07/07 | モルガン・スタンレーMUFG証券 | 1.02% | 再IN | 781,927株 |
| 07/07 | Nomura International plc | 0.53% | 再IN | 408,808株 |
| 07/02 | JPモルガン証券 | 1.1% | +0.08% | 842,851株 +58,200株 |
| 07/01 | GOLDMAN SACHS INTERNATIONAL | 1.1% | +0.01% | 846,704株 +31,500株 |
| 06/29 | Nomura International plc | 0.36% | -0.23% 義務消失 | 278,777株 -173,559株 |
| 06/26 | Nomura International plc | 0.59% | -0.05% | 452,336株 -41,464株 |
| 06/26 | JPモルガン証券 | 1.02% | +0.12% | 784,651株 +95,700株 |
| 06/25 | Barclays Capital Securities Ltd | 1.45% | +0.14% | 1,112,425株 +112,100株 |
| 06/22 | JPモルガン証券 | 0.9% | +0.1% | 688,951株 +76,700株 |
| 06/19 | Nomura International plc | 0.64% | 再IN | 493,800株 |
| 06/17 | Barclays Capital Securities Ltd | 1.31% | -0.09% | 1,000,325株 -73,700株 |
| 06/17 | Nomura International plc | 0.47% | -0.14% 義務消失 | 362,355株 -109,291株 |
| 06/16 | Nomura International plc | 0.61% | +0.01% | 471,646株 +7,179株 |
| 06/15 | Barclays Capital Securities Ltd | 1.4% | +0.07% | 1,074,025株 +55,000株 |
| 06/15 | JPモルガン証券 | 0.8% | +0.07% | 612,251株 +51,300株 |
| 06/12 | Barclays Capital Securities Ltd | 1.33% | +0.11% | 1,019,025株 +82,800株 |
| 06/11 | Barclays Capital Securities Ltd | 1.22% | +0.13% | 936,225株 +103,300株 |
| 06/11 | Nomura International plc | 0.6% | +0.06% | 464,467株 +45,628株 |
| 06/11 | JPモルガン証券 | 0.73% | +0.09% | 560,951株 +74,400株 |
| 06/10 | Barclays Capital Securities Ltd | 1.09% | -0.01% | 832,925株 -7,200株 |
| 06/10 | Nomura International plc | 0.54% | 再IN | 418,839株 |
| 06/09 | Barclays Capital Securities Ltd | 1.1% | +0.15% | 840,125株 +113,300株 |
| 06/08 | Barclays Capital Securities Ltd | 0.95% | +0.17% | 726,825株 +127,800株 |
| 06/05 | Barclays Capital Securities Ltd | 0.78% | -0.11% | 599,025株 -87,000株 |